XML 15 R41.htm IDEA: XBRL DOCUMENT v3.20.1
SEGMENT INFORMATION (Tables)
3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Schedule of segment revenues and profit
Segment revenues and profits were as follows:
 
Three Months Ended March 31,
(in millions)
2020
 
2019
Revenues:
 
 
 
Bausch + Lomb/International
$
1,114

 
$
1,118

Salix
477

 
445

Ortho Dermatologics
133

 
138

Diversified Products
288

 
315

 
$
2,012

 
$
2,016

 
 
 
 
Segment profits:
 
 
 
Bausch + Lomb/International
$
325

 
$
319

Salix
319

 
288

Ortho Dermatologics
48

 
57

Diversified Products
202

 
236

 
894

 
900

Corporate
(156
)
 
(125
)
Amortization of intangible assets
(436
)
 
(489
)
Goodwill impairments

 

Asset impairments
(14
)
 
(3
)
Restructuring and integration costs
(4
)
 
(20
)
Acquisition-related contingent consideration
(13
)
 
21

Other (expense) income, net
(23
)
 
3

Operating income
248

 
287

Interest income
7

 
4

Interest expense
(396
)
 
(406
)
Loss on extinguishment of debt
(24
)
 
(7
)
Foreign exchange and other
(13
)
 

Loss before benefit from income taxes
$
(178
)
 
$
(122
)

Schedule of revenues by segment and product category
Revenues by segment and product category were as follows:
 
Three Months Ended March 31, 2020
 
Three Months Ended March 31, 2019
(in millions)
Bausch + Lomb/ International
 
Salix
 
Ortho Dermatologics
 
Diversified Products
 
Total
 
Bausch + Lomb/ International
 
Salix
 
Ortho Dermatologics
 
Diversified Products
 
Total
Pharmaceuticals
$
201

 
$
477

 
$
77

 
$
182

 
$
937

 
$
217

 
$
445

 
$
95

 
$
211

 
$
968

Devices
341

 

 
51

 

 
392

 
366

 

 
38

 

 
404

OTC
351

 

 

 

 
351

 
324

 

 

 

 
324

Branded and Other Generics
203

 

 

 
103

 
306

 
191

 

 

 
102

 
293

Other revenues
18

 

 
5

 
3

 
26

 
20

 

 
5

 
2

 
27

 
$
1,114

 
$
477

 
$
133

 
$
288

 
$
2,012

 
$
1,118

 
$
445

 
$
138

 
$
315

 
$
2,016

Schedule of revenue attributed to a geographic region
Revenues are attributed to a geographic region based on the location of the customer and were as follows:
 
Three Months Ended March 31,
(in millions)
2020
 
2019
U.S. and Puerto Rico
$
1,211

 
$
1,200

Canada
90

 
79

Poland
73

 
62

Egypt
58

 
53

China
58

 
89

Japan
54

 
55

France
47

 
53

Germany
44

 
45

Mexico
41

 
46

Russia
34

 
36

United Kingdom
23

 
29

Spain
20

 
21

Italy
20

 
22

Other
239

 
226

 
$
2,012

 
$
2,016


Schedule of customers that accounted for 10% or more of total revenue
Customers that accounted for 10% or more of total revenues were as follows:
 
Three Months Ended March 31,
 
2020
 
2019
AmerisourceBergen Corporation
19%
 
16%
McKesson Corporation (including McKesson Specialty)
16%
 
17%
Cardinal Health, Inc.
13%
 
14%